IL-6 is a signaling protein (cytokine) produced by immune cells, muscle tissue, and fat cells in response to infection, injury, and metabolic stress. It drives the liver to produce acute-phase proteins like CRP and fibrinogen, making it an upstream inflammatory signal.
Elevated IL-6 is a central driver of "inflammaging", the chronic low-grade inflammation that accelerates cardiovascular disease, cognitive decline, and age-related dysfunction. It's more upstream than CRP, which means it reveals inflammatory activity before downstream markers respond. Exercise transiently raises IL-6 (which is actually beneficial), while chronic elevation indicates pathological inflammation. IL-6 is emerging as a key longevity target, with lower levels associated with healthier aging trajectories.
Optimal Interleukin-6: 0-2 pg/mL.
Typically re-tested every 8 weeks.
Because IL-6 moves quickly and responds to everyday things such as a hard training session or a cold, one reading is a snapshot. The pattern across repeat draws, read next to other inflammation markers, is what carries meaning.
Interleukin-6 is a cytokine, a small signalling protein cells use to talk to each other, and it is one of the main messengers the body uses to start, coordinate and later switch off an inflammatory response.
It is produced by many cell types rather than one organ. Monocytes and macrophages release it when they meet bacteria, viruses or damaged tissue. Endothelial cells lining blood vessels release it under stress. Fat tissue, particularly visceral fat around the organs, produces it steadily in the background. Skeletal muscle releases it during contraction, which is why it is also described as a myokine, and that muscle-derived signal behaves differently from the version released during infection.
IL-6 works through two routes. In classic signalling it binds a membrane-bound receptor found mainly on liver cells and some white blood cells, a route associated with tissue repair and resolution. In trans-signalling it binds a soluble form of its receptor, and the pair can then act on almost any cell in the body through a shared protein called gp130. The trans-signalling route is associated with much of the pro-inflammatory activity, which is part of why IL-6 is described as pleiotropic, meaning it does several different jobs depending on context.
Downstream, IL-6 instructs the liver to produce acute-phase proteins. That includes C-reactive protein, fibrinogen and hepcidin, the hormone that restricts how much iron is released into circulation. This connection explains why long-running inflammation often shows up as a rising CRP and a stubbornly low iron availability at the same time. IL-6 itself is released in pulses and clears from blood quickly, so it reacts faster than the proteins it triggers.
Related: Interleukin 6 Test Cost, What Changes the Price
It matters because persistently elevated IL-6 is one of the clearest blood signals of chronic low-grade inflammation, the slow background process researchers link with cardiovascular, metabolic and cognitive decline over decades.
In people receiving haemodialysis, plasma IL-6 has been studied as a predictor of cardiovascular mortality, with higher levels associated with worse outcomes[1]. Genetic work on the IL-6 receptor pathway suggests the signalling route itself, not only the circulating level, may play a part in vascular disease, including abdominal aortic aneurysm[2]. Even so, no single reading is predictive for one person.
Metabolic complications show a similar pattern. A systematic review and meta-analysis reported that IL-6 levels are associated with diabetic retinopathy, consistent with the idea that inflammatory signalling contributes to small-vessel damage in long-standing high blood sugar[3]. In oncology, serum IL-6 has been examined in relation to progression patterns in pancreatic ductal adenocarcinoma[4]. Studies indicate the marker also tracks with mental health states, with one meta-analysis examining IL-6 in serum, plasma and cerebrospinal fluid in individuals with suicide behaviour[5].
Read those together and the honest summary is this. IL-6 is a general-purpose inflammation signal that appears across many unrelated conditions, which makes it informative as a trend and useless as a standalone diagnostic. It is a reason to look closer, not an answer in itself.
Most laboratories report results using a typical reference range of 0 to 6 pg/mL, and many healthy adults sit near the bottom of it or below the assay's detection limit.
| Measure | Range | What it represents |
|---|---|---|
| Standard lab reference range | 0 to 6 pg/mL | Typical reporting range used by laboratories |
| FitScript optimal range | 0 to 2 pg/mL | FitScript's optimization target for the marker |
Serum cytokines were measured by flow cytometry in 299 healthy adults in East China. Women had a slightly higher IL-6 upper limit than men.[11]
| Sex | Age | Upper reference limit (pg/mL) |
|---|---|---|
| Women | Adults | up to 15.96 |
| Men | Adults | up to 14.61 |
Limits are the 95th percentile by sex, set separately because levels differed between sexes; flow cytometry bead assays can give different values than high-sensitivity immunoassays. Your own lab's printed range is the one to read your result against.
Typical lab reference ranges vary by laboratory, age and sex, and IL-6 varies more than most markers between assay platforms, so a result from one lab should not be compared directly with a result from another. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and a value above it is not a condition.
No separate age-banded or sex-specific optimal ranges are published here, so treat the single range above as the reference point and interpret any result next to your own earlier values. If your report uses different units or a different upper limit, use the range printed on that report rather than this one.
A high result means inflammatory signalling was active when the blood was drawn, and the useful next question is always what was driving it and whether it stays high on a repeat test.
People with elevated inflammatory markers often describe non-specific symptoms. Fatigue that sleep does not fix, aching joints or muscles, slower recovery after training, low mood or flat motivation, brain fog, reduced appetite, and during acute infection the familiar fever and malaise. None of those symptoms confirm anything on their own, and plenty of people with a raised reading feel entirely well.
Common contributors include recent or current infection, recent surgery or injury, intense or unaccustomed exercise in the days before the draw, higher visceral fat, smoking, short or fragmented sleep, periodontal disease, autoimmune conditions, chronic kidney disease, and ageing itself. Acute infection can move the marker dramatically. Systematic reviews during the COVID-19 pandemic found IL-6 levels were associated with disease severity, with higher concentrations reported in severe compared with non-severe cases[6], a finding echoed in a separate meta-analysis of severe COVID-19[7].
Over the long term, repeatedly elevated readings are associated with the cardiovascular and metabolic risks described above. That is a statistical association across populations, not a prediction about an individual.
The practical sequence is observation, then meaning, then next step. The observation is a number above the typical range. The meaning may be transient, something as ordinary as a virus two weeks ago, or it may reflect a persistent low-grade process worth understanding. The next step is a repeat test once any acute illness has resolved, read alongside other inflammatory markers, and a conversation with a clinician. A result that is markedly outside the standard range, or one that comes with fever, unexplained weight loss or persistent pain, is worth discussing with a clinician promptly rather than waiting for the next panel.
A low or undetectable result is the common finding in healthy adults and is generally regarded as unremarkable rather than a problem to correct.
There are no symptoms attributable to a low IL-6 reading. People at the bottom of the range usually feel the same as anyone else, and in the context of an optimization panel a low value simply suggests little inflammatory signalling was happening at that moment.
The usual causes are straightforward. No active infection or injury, low visceral fat, good sleep, and no flaring autoimmune process. Assay sensitivity matters too, since some platforms cannot measure below a floor and report anything beneath it as undetectable. Medications with anti-inflammatory activity can also lower circulating levels, which is one reason your medication list belongs with your result.
Long term, there is no established benefit in deliberately pushing IL-6 toward zero. The cytokine has genuine roles in immune defence, tissue repair and the muscle response to exercise, and laboratories regard the lower end of the range as normal rather than deficient. One caveat worth knowing is that in people receiving medications that block the IL-6 receptor, measured levels can behave counterintuitively because the blocked receptor changes how the cytokine is cleared, so results in that setting need interpretation by the prescribing clinician.
Quite a lot, which is why testing conditions deserve as much attention as the number itself.
Testing conditions. IL-6 follows a daily rhythm and is typically higher in the early morning hours, so draw time matters for comparing results. A hard endurance or resistance session can produce a large transient rise that settles within hours to a day. An infection in the preceding weeks, a dental procedure, a vaccination response or a recent injury can all lift a reading temporarily. Sample handling and the specific assay used add further variation, so repeat testing through the same laboratory makes trends far more readable. Follow whatever fasting and timing instructions your lab prints on the requisition, since these differ between providers.
Medications. Several drug classes are associated with changes in circulating IL-6. A systematic review and meta-analysis of rosuvastatin in people living with HIV reported effects on inflammatory markers including IL-6 and high-sensitivity C-reactive protein[8], and a separate review examined how protease inhibitor based antiretroviral therapy relates to serum and plasma IL-6 levels in the same population[9]. None of that is a reason to change a medication, and a licensed provider evaluates whether any prescription therapy is appropriate for a given person.
Habits and supplements. Sleep duration, visceral fat, smoking, alcohol intake, dietary pattern and training load all appear to track with inflammatory signalling, though cause and effect is unclear. Some supplement trials report reductions in inflammatory markers, for example an updated systematic review and dose-response meta-analysis of propolis supplementation and serum IL-6, CRP and TNF-alpha[10], though effects in trials are modest and no doses or schedules are given here. This page covers what the marker means rather than how to shift it, and changes to supplements or medication belong in a conversation with a clinician.
IL-6 is measured from a standard blood draw as part of an advanced inflammation workup, sitting alongside the other inflammatory markers rather than being read in isolation.
Within a FitScript membership, inflammatory markers are part of a wider testing schedule of 150+ biomarkers tested per year, which means a single IL-6 value is usually read next to earlier draws and next to metabolic, hormonal and cardiovascular results from the same period. Atlas, FitScript's AI health advisor, interprets the result in that context and writes it into your FitScript, the personalised output built from your own biology, including which markers to recheck and when.
Where a result suggests something that may need clinical attention, or where a prescription option comes into the conversation, a licensed provider reviews the member and decides whether any therapy is appropriate. Nothing on this page is a recommendation for a specific medication.
This article is educational and is not medical advice. Discuss your own results, your medication list and any treatment decisions with a clinician or licensed provider who can see your full history.
IL-6 becomes far more interpretable when it is read as part of an inflammatory panel, because each marker captures a different part of the same process and a different timescale.
C-reactive protein is the downstream protein the liver makes in response to IL-6 signalling, and it moves more slowly, which makes the pair useful together for separating a recent spike from a sustained pattern. TNF-alpha is another upstream cytokine that often rises in parallel and helps show whether inflammatory signalling is broad or narrow. Fibrinogen activity links inflammation with clotting, since it is both an acute-phase protein and a direct contributor to blood viscosity. ESR is an older, non-specific measure of inflammation that reacts over days to weeks and provides a slower-moving comparison. Homocysteine sits at the intersection of B-vitamin status and vascular risk, offering a different angle on the same cardiovascular picture. Myeloperoxidase reflects neutrophil activity and oxidative stress within the artery wall, which is a more vessel-specific read than a general cytokine.
Read together, these markers tell you whether an elevated cytokine is an isolated blip or part of a coherent inflammatory pattern worth investigating with a clinician.
Interleukin-6 is a fast-moving inflammatory messenger, not a diagnosis. A result above the typical range means something was stimulating inflammatory signalling at the time of the draw, and the cause could be as ordinary as last week's cold or last night's training session, or as relevant as visceral fat, poor sleep or an unrecognised chronic process. Low values are normal. The useful move is always the same, repeat the test under comparable conditions, read it beside related markers, and take the pattern to a clinician rather than acting on a single number.
You can read more about the related markers here, C-Reactive Protein, TNF-alpha, Fibrinogen Activity, Homocysteine, ESR and Myeloperoxidase, or see how they are measured together on the Advanced Inflammation panel.
It measures how much interleukin-6 is circulating in your blood at the moment of the draw, reported in picograms per millilitre. IL-6 is a cytokine released by immune cells, fat tissue, blood vessel lining and working muscle, so the result reflects current inflammatory signalling rather than any specific disease.
No, they sit at different points in the same chain. IL-6 is an upstream signal released by cells, and C-reactive protein is a downstream protein the liver produces in response to that signal. IL-6 moves faster and clears faster, while CRP reflects a slower average, which is why the two are often read together.
Many laboratories use a typical reference range of 0 to 6 pg/mL, and plenty of healthy adults sit near the floor of the assay. FitScript's optimal range is 0 to 2 pg/mL, which is an optimization target rather than a diagnostic cut-off. Ranges vary by lab, age and sex, so use the range printed on your own report.
Yes. Contracting skeletal muscle releases IL-6, and an intense or unfamiliar session can produce a large temporary rise that settles within hours to around a day. That muscle-derived release is a normal exercise response, not a sign of illness, which is why timing your draw away from hard training makes results easier to compare.
No. A single elevated value shows that inflammatory signalling was active when blood was taken, and the cause may be as ordinary as a recent infection, a hard workout, poor sleep or a dental issue. It does not identify a condition. A repeat test after any acute illness has resolved, read alongside other markers and reviewed by a clinician, is the sensible next step.
Requirements differ between laboratories, so follow the instructions printed on your requisition. More important for this marker is consistency, draw at a similar time of day, avoid testing during an acute infection or soon after intense training, and use the same laboratory for follow-up so the numbers are comparable.
Usually that little inflammatory signalling was happening, which is the common finding in healthy adults. Some assays simply cannot measure below a floor and report anything beneath it as undetectable. There is no established benefit in deliberately driving IL-6 lower, since the cytokine has real roles in immune defence, tissue repair and the muscle response to exercise.
Because the marker is volatile, the trend across several draws is more informative than any single value. Retesting intervals depend on why it was ordered and what else your results show, so that decision belongs with your clinician. Within FitScript, inflammatory markers form part of a recurring testing schedule and Atlas flags which ones to recheck and when.